OLUSOLA ASAFA: Open Payments
NPI 1467969485 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 40 payments from 12 companies in 2025. Trend: 2023 $378 · 2024 $720 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $213 |
| PFIZER INC. | 9 | $202 |
| Merck Sharp & Dohme LLC | 6 | $170 |
| ABBVIE INC. | 5 | $83 |
| Braeburn Inc. | 3 | $64 |
| ViiV Healthcare Company | 2 | $49 |
| Lilly USA, LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $29 |
| SANOFI PASTEUR INC. | 1 | $26 |
Products named: NURTEC ODT, PIFELTRO, Rybelsus, Ozempic, UBRELVY, BRIXADI, APRETUDE, MOUNJARO.
Industry payments across CA — which companies pay providers there.
